(Q33236176)

24 July 2017

title

Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy (English)

1 reference

proliferative vitreoretinopathy

24 July 2017

main subject

1 reference

Cui JZ

1

1 reference

24 July 2017

Chiu A

2

1 reference

24 July 2017

Maberley D

3

1 reference

24 July 2017

Ma P

4

1 reference

24 July 2017

Samad A

5

1 reference

24 July 2017

Matsubara JA

6

1 reference

24 July 2017

publication date

10 March 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

21

1 reference

24 July 2017

issue

2

1 reference

24 July 2017

page(s)

200-208

1 reference

Growth factors in proliferative vitreoretinopathy

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Hepatocyte growth factor (HGF/SF) in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

CCN proteins: multifunctional signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Connective tissue growth factor: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Hepatocyte growth factor and its role in the pathogenesis of retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Emerging multipotent aspects of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Hepatocyte growth factor: a multifunctional cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

[Mononuclear phagocytes and their growth factors: pacemakers of proliferative vitreoretinopathy?]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Strategies to influence PVR development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

Adjuvant 5-FU and heparin prevent PVR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

The classification of retinal detachment with proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

7 January 2021

Cellular components of subretinal membranes in proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

7 January 2021

Inflammatory cells in proliferative vitreoretinopathy subretinal membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

7 January 2021

Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7.5 and 14.5 of gestation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

7 January 2021

Induction of hepatocyte growth factor (HGF) in rat microglial cells by prostaglandin E(2)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

7 January 2021

Expression of Growth Factor Mrna in Rabbit Pvr Model Systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

7 January 2021

Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

7 January 2021

Oral colchicine for the treatment of experimental traction retinal detachment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

7 January 2021

Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702169

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6702169

1 reference

Dimensions Publication ID

24 July 2017

1002642285

0 references

1 reference